Toggle navigation
Home
Pulse
Channels
CME
Profile
Home
Pulse
Channels
CME
Profile
tmodarressi's Talks
@tmodarressi
Advocare Princeton Cardiometabolic Health
Delay in Statin Therapy in T2D
April 27, 2026
@tmodarressi
Advocare Princeton Cardiometabolic Health
VESALIUS-CV: Reduced CV Risk in T2D with Evolocumab
April 27, 2026
Share
VESALIUS-CV: Reduced CV Risk in T2D with Evolocumab
https://www.medspoke.co/channel_playlist?object_id=804&tap_id=11088
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
@tmodarressi
Advocare Princeton Cardiometabolic Health
Once-Weekly Insulin Icodec (Awiqli) Approved for T2D
April 27, 2026
Why are you reporting this TALK?
